Zymeworks Inc. Common Stock (ZYME) — Cash Flow-to-Debt Ratio
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow-to-Debt Ratio of -0.41x as of September 2025, meaning its operating cash flow of $-31.41 Million could theoretically repay 0% of its total liabilities ($77.20 Million) in one year. See financial flexibility index of Zymeworks Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zymeworks Inc. Common Stock Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Zymeworks Inc. Common Stock across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zymeworks Inc. Common Stock.
Annual Cash Flow-to-Debt Ratio for Zymeworks Inc. Common Stock (2014–2024)
Year-by-year debt coverage analysis for Zymeworks Inc. Common Stock. Check ZYME cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.89x | $-110.04 Million | $124.32 Million | ▲ +13.2% |
| 2023 | -1.02x | $-118.30 Million | $116.07 Million | ▼ -210.2% |
| 2022 | 0.93x | $144.11 Million | $155.77 Million | ▲ +167.3% |
| 2021 | -1.37x | $-192.45 Million | $140.04 Million | ▼ -16.6% |
| 2020 | -1.18x | $-151.40 Million | $128.45 Million | ▼ -76.4% |
| 2019 | -0.67x | $-81.85 Million | $122.52 Million | ▼ -276.5% |
| 2018 | 0.38x | $24.18 Million | $63.87 Million | ▲ +2583.7% |
| 2017 | 0.01x | $219.00K | $15.53 Million | ▲ +103.4% |
| 2016 | -0.41x | $-35.25 Million | $84.99 Million | ▲ +90.8% |
| 2015 | -4.52x | $-22.17 Million | $4.91 Million | ▼ -601.8% |
| 2014 | -0.64x | $-7.02 Million | $10.90 Million | — |